treadmill < treat < treated

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by treat

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]

Ident.	Authors (with country if any)	Title
000053 (2020)	Jean-Marie Michot [France] ; Laurence Albiges [France] ; Nathalie Chaput [France] ; Veronique Saada [France] ; Fanny Pommeret [France] ; Franck Griscelli [France] ; Corinne Balleyguier [France] ; Benjamin Besse [France] ; Aurélien Marabelle [France] ; Florence Netzer [France] ; Mansouria Merad [France] ; Caroline Robert [France] ; Fabrice Barlesi [France] ; Bertrand Gachot [France] ; Annabelle Stoclin [France]	Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report
000460 (2020)	Celine J. Van De Laar ; Martijn A H. Oude Voshaar ; Walid K H. Fakhouri [États-Unis] ; Liliana Zaremba-Pechmann [États-Unis] ; Francesco De Leonardis [États-Unis] ; Inmaculada De La Torre [États-Unis] ; Mart A F J. Van De Laar	Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
000A96 (2019)	Vasco C. Romão [Portugal] ; João Eurico Fonseca [Portugal]	Major Challenges in Rheumatology: Will We Ever Treat Smarter, Instead of Just Harder?
000B65 (2019)	Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]	Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000C32 (2019)	Peter. C. Taylor [Royaume-Uni] ; Alejandro Balsa Criado ; Anne-Barbara Mongey ; Jerome Avouac ; Hubert Marotte ; Rudiger B. Mueller	How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy
000D63 (2019)	L. E. Burgers [Pays-Bas] ; J. A. Van Der Pol [Pays-Bas] ; T. W. J. Huizinga [Pays-Bas] ; C. F. Allaart [Pays-Bas] ; A. H. M. Van Der Helm-Van Mil [Pays-Bas]	Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care
000F58 (2019)	Annalisa Chiappella [Italie] ; Jennifer Crombie [États-Unis] ; Anna Guidetti [Italie] ; Umberto Vitolo [Italie] ; Philippe Armand [États-Unis] ; Paolo Corradini [Italie]	Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
001043 (2019)	Bernard Dyke [Royaume-Uni] ; Caroline Gordon [Royaume-Uni] ; Phillip Hawkins [Royaume-Uni] ; Sofia Tosounidou [Royaume-Uni]	9. Successful use of IL-6 pathway blockade to treat autoinflammation occurring in the context of a novel TNFRS1A gene mutation
001239 (2018)	Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]	Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies.
001271 (2018)	Ju-Yang Jung [Corée du Sud] ; Moon-Young Kim [Corée du Sud] ; Chang-Hee Suh [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]	Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review.
001340 (2018)	Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Pascal H P. De Jong [Pays-Bas] ; Johanna M W. Hazes [Pays-Bas] ; Angelique E A M. Weel [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]	Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
001381 (2018)	Anna Ohradanova-Repic [Autriche] ; Christian Machacek [Autriche] ; Celine Charvet [France] ; Franck Lager [France] ; Delphine Le Roux [France] ; René Platzer [Autriche] ; Vladimir Leksa [Autriche, Slovaquie] ; Goran Mitulovic [Autriche] ; Thomas R. Burkard [Autriche] ; Gerhard J. Zlabinger [Autriche] ; Michael B. Fischer [Autriche] ; Vincent Feuillet [France] ; Gilles Renault [France] ; Stephan Blüml [Autriche] ; Miroslav Benko ; Miloslav Suchanek ; Johannes B. Huppa [Autriche] ; Takami Matsuyama [Japon] ; Artur Cavaco-Paulo [Portugal] ; Georges Bismuth [France] ; Hannes Stockinger [Autriche]	Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances
001478 (2018)	Xavier M. Teitsma [Pays-Bas] ; Wei Yang [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Amy C. Harms [Pays-Bas] ; Thomas Hankemeier [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas]	Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology.
001567 (2017)	Aly M. Aly [Égypte] ; Daniel E. Furst [États-Unis]	Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic review.
001750 (2017)	Maurizio Benucci ; Roberto Ravasio [Italie] ; Arianna Damiani	Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate.
001806 (2017)	Philippe Saas [France] ; Francis Bonnefoy [France] ; Eric Toussirot [France] ; Sylvain Perruche [France]	Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
001851 (2017)	Noelle Frey [États-Unis]	Cytokine release syndrome: Who is at risk and how to treat.
002090 (2015)	David Ternant [France] ; Theodora Bejan-Angoulvant [France] ; Christophe Passot [France] ; Denis Mulleman [France] ; Gilles Paintaud [France]	Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
002123 (2015)	Nathalie Esser [Belgique] ; Nicolas Paquot ; André J. Scheen	Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
002537 (2014)	Mo Yin Mok [Hong Kong] ; Debashish Danda [Inde]	‘Treat to target’ for rheumatoid arthritis in 2014 – time tested triple therapy or logical Biologics?
002A73 (2013)	I. E. Lundberg [Suède]	SP0131 How to treat

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "treat" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "treat" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    treat
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021